RANBAXY HIT, LOW US PRICES PINCH INDIAN DRUGMAKERS

India's top drug maker, Ranbaxy Laboratories Ltd., will show a sharp drop in quarterly earnings amid price pressure in the generic market abroad and high costs, while its rivals will post varied results, a Reuters poll showed. These companies have targeted higher revenue contributions from the United States and Europe to tap the growing market for generic medicines, which Indian drug makers are skilled at developing, although they are feeling the pinch of competition.

Boston Globe (http://www.boston.com/news/world/asia/articles/2006/01/17/ranbaxy_hit_low_us_prices_pinch_indian_drugmakers/)